Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 6 de jun. de 2024 · While some insights on the role of innate and adaptive immune cells in chronic ischemic HF may be gleaned from studies of wound healing after acute MI, their precise contributions to the pathogenesis of ischemic cardiomyopathy are less well understood.

  2. 31 de may. de 2024 · The newest clinical guideline released by the ACC and the American Heart Association provides the latest evidence-based recommendations for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM).

  3. 7 de jun. de 2024 · Hypertrophic cardiomyopathy (HCM) is an autosomal dominant cardiac myocyte disease caused by mutations in sarcomere and sarcomere-related protein genes encoding for elements of the contractile machinery of the heart.

  4. 31 de may. de 2024 · Ischemia and no obstructive coronary artery disease (INOCA) is increasingly recognized and associated with poor outcomes. The triglyceride-glucose (TyG) index is a reliable alternative measure of insulin resistance significantly linked to cardiovascular disease and adverse prognosis.

  5. Hace 6 días · Abstract: Ischemic cardiomyopathy patients with severe left ventricular dysfunction are a specific group of patients with poor surgical outcomes. There are few surgical treatment options in practice

  6. 31 de may. de 2024 · In all three types of ischemia, the damaged cardiomyocytes and ECM release damage associated molecular patterns (DAMPs) to activate pattern recognition receptors (PRRs) on the surviving ...

  7. 20 de jun. de 2024 · Recent observational data by Fastner et al. suggest a greater LVEF response to CCM in patients with non-ischemic as compared to ischemic cardiomyopathy, for reasons not entirely clear (2). Two recent case reports have highlighted a potential role of genetic cardiomyopathy (GCM) for significant response to CCM in patients with ...